Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2706488 | 1.00 | MAPK1 (0.32) | MAPK1NPSR1 | |
| SCHEMBL6470444 | 0.82 | — | — | |
| SCHEMBL1685367 | 0.76 | KDM4E (0.31) | — | |
| SCHEMBL3293871 | 0.74 | KMT2A (0.31) | — | |
| SCHEMBL13342645 | 0.72 | L3MBTL1 (0.37) | MAPK1 | |
| SCHEMBL9488890 | 0.71 | CHRM2 (0.31) | — | |
| SCHEMBL12849082 | 0.71 | TRPA1 (0.40) | — | |
| SCHEMBL14583496 | 0.70 | KMT2A (0.39) | — | |
| SCHEMBL10986631 | 0.69 | — | — | |
| SCHEMBL11089761 | 0.67 | TERT (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116903654-A | Hydrophobic modifier, preparation method thereof and method for preparing modified inorganic filler | 南开大学 | 2023-10-20 | — | — | CN | claimed |
| CN-116903654-A | Hydrophobic modifier, preparation method thereof and method for preparing modified inorganic filler | 南开大学 | 2023-10-20 | — | — | CN | disclosed |
| WO-2021132234-A1 | MULTILAYER BODY | 住友化学株式会社 | 2021-07-01 | — | — | WO | disclosed |
| WO-2021132236-A1 | OPTICAL LAMINATE | 住友化学株式会社 | 2021-07-01 | — | — | WO | disclosed |
| US-20150315188-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF HYPERTENSION | MEDIVATION TECHNOLOGIES, INC. | 2015-11-05 | — | — | US | disclosed |
| EP-2887805-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF HYPERTENSION | Medivation Technologies, Inc. (US) | 2015-07-01 | — | — | EP | disclosed |
| WO-2014031167-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF HYPERTENSION | MEDIVATION TECHNOLOGIES, INC. (US) | 2014-02-27 | — | — | WO | disclosed |
| WO-2014031170-A1 | PYRIDO[4,3-B]INDOLE AND PYRIDO[3,4-B]INDOLE DERIVATIVES AND METHODS OF USE | MEDIVATION TECHNOLOGIES, INC. (US) | 2014-02-27 | — | — | WO | disclosed |
| WO-2014031165-A1 | COMPOUNDS AND METHODS OF TREATING DIABETES | MEDIVATION TECHNOLOGIES, INC. (US) | 2014-02-27 | — | — | WO | disclosed |
| CN-101400664-B | Method for crystallization of epoxy compound | SUMITOMO CO LTD | 2012-09-05 | — | — | CN | disclosed |
| US-8198069-B2 | Method of producing an optically enriched tertiary alcohol from an epoxide using halohydrin dehalogenase | BASF SE (DE) | 2012-06-12 | — | — | US | disclosed |
| EP-1966385-B1 | A process for the production of an optically enriched tertiary alcohol | BASF SE (DE) | 2012-05-02 | — | — | EP | disclosed |
| US-20080299626-A1 | Process For the Production of an Optically Enriched Tertiary Alcohol | BASF AKTIENGESELLSCHAFT (DE) | 2008-12-04 | — | — | US | disclosed |
| EP-1966385-A2 | A PROCESS FOR THE PRODUCTION OF AN OPTICALLY ENRICHED TERTIARY ALCOHOL | BASF SE (DE) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007071599-A2 | A PROCESS FOR THE PRODUCTION OF AN OPTICALLY ENRICHED TERTIARY ALCOHOL | BASF SE (DE) | 2007-06-28 | — | — | WO | disclosed |
| EP-0099375-B1 | PROCESS FOR TREATING USED MOTOR OIL AND SYNTHETIC CRUDE OIL | NORMAN, George R. (US) | 1987-09-02 | — | — | EP | disclosed |
| US-4432865-A | REACTING WITH MINERAL ACID OR POLYHYDROXY COMPOUND, THEN SEPARATION | NORMAN GEORGE R | 1984-02-21 | — | — | US | disclosed |
| US-4431524-A | DEMETALLIZATION BY ADDING A MINERAL ACID AND POLYHYDROXY COMPOUND SUCH AS CELLULOSE FIBERS | NORMAN GEORGE R | 1984-02-14 | — | — | US | disclosed |
| US-4382128-A | Polyolefin grafted with polycarboxylic acid, ester or anhydride and modified with polyhydroxy compound | STANDARD OIL COMPANY (US) | 1983-05-03 | — | — | US | disclosed |
| US-4144027-A | SHRINKPROOFING KERATIN-CONTAINING FABRICS BY REACTION WITH A POLYETHER POLYOL AND A DIISOCYANATE | MILLIKEN RESEARCH CORPORATION (US) | 1979-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150315188-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF HYPERTENSION | ADRB2, ADRA2B, ADRB1 | MAPK1 1470/4885NPSR1 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.